Skip to main content

Advertisement

Figure 3 | AIDS Research and Therapy

Figure 3

From: NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials

Figure 3

Mean percent change in NPRS score. Change in NPRS score from baseline to Weeks 2–12 for the 30-minute treatment groups. Analysis by subgroup: (A) gender; (B) baseline pain score; (C) concomitant neuropathic pain medication use; and (D) duration of HIV-DSP. *A patient was defined as receiving concomitant neuropathic pain medication if he or she was taking an anticonvulsant, non-SSRI antidepressant, or opioid on Day −1 and for a total duration of at least 7 consecutive days.

Back to article page